EndoShape reports raising $1.8M in new funds

BOULDER — Medical-device company EndoShape Inc., has raised about $1.8 million in new funding, according to a recent filing made with the U.S. Securities and Exchange Commission.

A company official on Wednesday said he couldn’t comment on the funding at this time.

According to the filing, the new funds add to a funding round first disclosed last year that had reached about $1.2 million at that point.

SPONSORED CONTENT

How dispatchable resources enable the clean energy transition

Platte River must prepare for the retirement of 431 megawatts (MW) of dispatchable, coal-fired generation by the end of the decade and address more frequent extreme weather events that can bring dark calms (periods when there is no sun or wind).

EndoShape’s Medusa MultiCoil is a device used for the embolization, or blocking, of blood vessels. It’s used to close off vessels that might be ruptured and causing internal bleeding or vessels that are feeding a tumor.

EndoShape received U.S. Food and Drug Administration approval for the device in 2013. That clearance was followed by a $5.9 million funding round in 2014.